← FDA Drug Approvals (Drugs@FDA)
HALOPERIDOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS GROUP · Approved 2022-07-01
Drug application
- FDA Application #
ANDA200854- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HALOPERIDOL
- Generic name
- Haloperidol
- Active ingredients
- HALOPERIDOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- ACTAVIS GROUP
- First approval
- 2022-07-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown